Biomedical engineers at Duke University have integrated automated wet lab techniques with sophisticated artificial intelligence to revolutionize the design of nanoparticles for targeted drug delivery. This AI-enhanced approach aims to overcome traditional challenges in therapeutic formulation by optimizing nanoparticle constructs for efficiency and efficacy. The synergy of wet lab automation and AI data analytics promises to accelerate the discovery of next-generation drug delivery vehicles, improving precision medicine capabilities.